After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Insmed Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $28.44 and fluctuated between $29.21 as its day high and $28.03 as its day low. The current market capitalization of Insmed Inc is $4.07B. A total of 1.13 million shares were traded on the day, compared to an average of 1.56M shares.
Insider Activity
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, INSM has seen 7 BUY and 6 SELL insider trades, representing the acquisition of 112,500 and the disposition of 112,000 shares. Over the last 12 months, there were 29 BUYs and 31 SELLs from insiders. Insiders purchased 783,038 shares during that period but sold 182,885.
In the most recent transaction, Adsett Roger sold 5,251 shares of INSM for 28.63 per share on Jan 12. After the transaction, the Chief Operating Officer now owns 148,559 company shares. In a previous transaction on Jan 12, Flammer Martina M.D. sold 4,667 shares at 28.63 per share. INSM shares that Chief Medical Officer owns now total 106,898.
Among the insiders who sold shares, Adsett Roger disposed of 3,536 shares on Jan 10 at a per-share price of $28.90. This resulted in the Chief Operating Officer holding 153,810 shares of INSM after the transaction. In another insider transaction, Flammer Martina M.D. sold 1,245 shares at $28.90 per share on Jan 10. Company shares held by the Chief Medical Officer now total 111,565.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for INSM in the last 3 months, the mean price target is $42.54 with high estimates of $55.00 and low estimates of $35.00. In terms of 52-week highs and lows, INSM has a high of $32.00 and a low of $16.04.
As of this writing, INSM has an earnings estimate of $International Seaways, Inc. per share for the current quarter. EPS was calculated based on a consensus of Inseego Corp. estimates, with a high estimate of $Inspire Medical Systems, Inc. per share and a lower estimate of $Insmed Incorporated.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. INSM’s latest balance sheet shows that the firm has $716.78M in Cash & Short Term Investments as of fiscal 2021. There were $612.27M in debt and $135.17M in liabilities at the time. Its Book Value Per Share was -$2.02, while its Total Shareholder’s Equity was $410.47M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for INSM is Buy with a score of 5.00.
